NewAmsterdam Pharma Warrant
NAMSW
9 hedge funds and large institutions have $22.2M invested in NewAmsterdam Pharma Warrant in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
113% more capital invested
Capital invested by funds: $10.4M → $22.2M (+$11.8M)
0.09% less ownership
Funds ownership: 28.34% → 28.25% (-0.09%)
10% less funds holding
Funds holding: 10 → 9 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$22.5K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$16.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.19K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FLSM
1
Frazier Life Sciences Management
Palo Alto,
California
| $8.56M | – | – | – |
|
|
RCM
2
RA Capital Management
Boston,
Massachusetts
| $5.7M | – | – | – |
|
|
AAA
3
Affinity Asset Advisors
New York
| $4.19M | – | – | – |
|
|
BCLSI
4
Bain Capital Life Sciences Investors
Boston,
Massachusetts
| $1.71M | – | – | – |
|
|
DM
5
Deerfield Management
New York
| $1.59M | – | – | – |
|
|
LCM
6
Laurion Capital Management
New York
| $285K | – | – | – |
|
|
VI
7
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $165K | – | – | – |
|
|
8
CIBC Private Wealth Group
Atlanta,
Georgia
| $22.4K | -$22.5K | -1,750 | -58% |
|
|
9
UBS Group
Zurich,
Switzerland
| $8.76K | -$6.19K | -481 | -48% |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| – | -$16.7K | -2,091 | Closed |
|
NAMSW Hedge Fund Activity: Q3 2025 in Review
9 of the 7,624 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q3 2025, worth a combined $22.2M — up 113% from $10.4M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NAMSW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was CIBC Private Wealth Group, cutting an estimated $22.5K.
- 9 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q3 2025, down from 10 in Q2 2025.
- Funds reported $22.2M of NewAmsterdam Pharma Warrant stock for Q3 2025, up 113% quarter-over-quarter.
- 0 funds opened new NewAmsterdam Pharma Warrant positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest NewAmsterdam Pharma Warrant seller in Q3 2025 was CIBC Private Wealth Group, an estimated $22.5K sold.
Based on aggregated 13F filings for Q3 2025.